Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s DiseaseHendrik Wesseling, Judith A. Steen, Simon Dujardin et al.|Cell|2020Cited by 715
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetesShuko Takeda, Ryuichi Morishita|Proceedings of the National Academy of Sciences|2010Cited by 501
Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer’s disease brainShuko Takeda, Bradley T. Hyman, Susanne Wegmann et al.|Nature Communications|2015Cited by 378
Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β PeptideTadafumi Hashimoto, Bradley T. Hyman, Alberto Serrano‐Pozo et al.|Journal of Neuroscience|2012Cited by 291
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s DiseaseBence György, Martin Ingelsson, Camilla Lööv et al.|Molecular Therapy — Nucleic Acids|2018Cited by 189